Journal of Radiation Research and Radiation ProcessingVol. 17, Issue 4, Pages: 204-208(1999)
作者机构:
1.中国医学科学院、中国协和医科大学放射医学研究所 天津 300192
作者简介:
基金信息:
a grant from Tianjin Youth Natural Science Foundation
DOI:
CLC:
扫 描 看 全 文
ZHANG Yuguang, ZHANG Xinru, YAN Yujung, et al. THE RESEARCH OF E838 IN TUMOR RADIOTHERAPY. [J]. Journal of Radiation Research and Radiation Processing 17(4):204-208(1999)
DOI:
ZHANG Yuguang, ZHANG Xinru, YAN Yujung, et al. THE RESEARCH OF E838 IN TUMOR RADIOTHERAPY. [J]. Journal of Radiation Research and Radiation Processing 17(4):204-208(1999)DOI:
E838 is a better radioprotecter that is derivative of estrogen. E838 inhibits cell proliferation of MCF7 cell line in vitro,D,0, is 3.9,µ,g/mL,IC,50, is 5.6,µ,g/mL. It also inhibits the growth of tumor bearing mice that extend the living time and enhance the effect of radiotherapy. Up till now, E838 haven't been fond the effect of stimulate and promote tumor metastasis. E838 has the possibility as an auxiliary medicine using in radiotherapy of tumors.
Effect of Quercetin on radiosensitivity of human Uterine Cervix Cancer HeLa cells
APOPTOSIS IN HeLa CELL EXPOSED TO DIFFERENT DOSE、DOSE—RATE OF 32P β-IRRADIATION AND THE CORRELATION WITH CELL—KILLING EFFECACY
EFFECTS OF E838 ON THE SURVIVAL AND HEMATOPOIETIC FUNCTION OF RADIATION INJURED MICE
THE EFFECT OF RADIATION INJURY ON THE PROLIFERATION CAPACITY OF BONE MARROW HEMATOPOIETIC CELLS IN VIVO
TH E EFFECTIVE OF PROLIFERATION IN THE SMALL INTESTINAL CRYPTS OF THE MOUSE FOLLOWING IN VIVO ADMINISTRATION OF GROWTH FACTOR TGFβ 3
Related Author
No data
Related Institution
School of Radiation Medicine and Public Health, Medical College of Suzhou University, Jiangsu Provincial key Laboratory of Radiation Medicine and Protection
Department of Nuclear Medicine, The General Hospital of PLA
Beijing Institute of Radiation Medicine
Institute of Combined Injuries, Third Military Medical University